Tag Archives: Cord Dohrmann

Evotec and Esperion Achieve Key Milestone with Preclinical Candidate for Rare Liver Disease Primary Sclerosing Cholangitis

(IN BRIEF) Evotec SE has announced that Esperion Therapeutics has nominated an oral preclinical development candidate for primary sclerosing cholangitis (PSC), marking a major milestone in their collaboration. The PDC, developed through Evotec’s integrated small molecule discovery platform and Esperion’s … Read the full press release

Evotec Achieves Major Milestones in Molecular Glue Degrader Collaboration with Bristol Myers Squibb, Unlocks $75 Million in Payments

(IN BRIEF) Evotec SE has reached key milestones in its molecular glue degrader collaboration with Bristol Myers Squibb, earning $75 million in performance- and program-based payments. The partnership, built on Evotec’s AI-driven drug discovery platforms and BMS’s CELMoD™ technology, continues … Read the full press release